pentoxifylline has been researched along with AIDS Seroconversion in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tumor necrosis factor-alpha (TNF-alpha) is thought to induce cachexia in subjects infected with human immunodeficiency virus (HIV), and it has been suggested that HIV-seropositive patients would benefit from treatment with pentoxifylline, a known suppressor of TNF-alpha production." | 5.08 | Pentoxifylline therapy in HIV seropositive subjects with elevated TNF. ( Bruunsgaard, H; Kappel, M; Kruse, A; Orholm, M; Pedersen, BK; Rieneck, K; Skinhøj, P; Ullum, H, 1995) |
| "The causes of pruritus are numerous including xerosis, drug and photoeruptions, follicular and papular eruptions as well as infestations and infections by a wide range of organisms." | 2.68 | Pruritus in HIV-1 disease: therapy with drugs which may modulate the pattern of immune dysregulation. ( Lee, RB; Skelton, HG; Smith, KJ; Wagner, KF; Yeager, J, 1997) |
| "Pentoxifylline (PTX) has potential usefulness in HIV-seropositive patients due to its beneficial effects on renal function, its inhibitory effects on tumor necrosis factor alpha, and its vascular effects on microcirculatory disturbances." | 2.67 | Influence of pentoxifylline on renal function in HIV-seropositive patients. ( Bell, N; Dennis, S; Luke, DR; Sarnoski, TP, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luke, DR | 1 |
| Sarnoski, TP | 1 |
| Bell, N | 1 |
| Dennis, S | 1 |
| Kruse, A | 1 |
| Rieneck, K | 1 |
| Kappel, M | 1 |
| Orholm, M | 1 |
| Bruunsgaard, H | 1 |
| Ullum, H | 1 |
| Skinhøj, P | 1 |
| Pedersen, BK | 1 |
| Wallis, RS | 1 |
| Nsubuga, P | 1 |
| Whalen, C | 1 |
| Mugerwa, RD | 1 |
| Okwera, A | 1 |
| Oette, D | 1 |
| Jackson, JB | 1 |
| Johnson, JL | 1 |
| Ellner, JJ | 1 |
| Clerici, M | 1 |
| Piconi, S | 1 |
| Balotta, C | 1 |
| Trabattoni, D | 1 |
| Capetti, A | 1 |
| Fusi, ML | 1 |
| Ruzzante, S | 1 |
| Longhi, R | 1 |
| Colombo, MC | 1 |
| Moroni, M | 1 |
| Milazzo, F | 1 |
| Smith, KJ | 1 |
| Skelton, HG | 1 |
| Yeager, J | 1 |
| Lee, RB | 1 |
| Wagner, KF | 1 |
5 trials available for pentoxifylline and AIDS Seroconversion
| Article | Year |
|---|---|
Influence of pentoxifylline on renal function in HIV-seropositive patients.
Topics: Adult; Analysis of Variance; Drug Therapy, Combination; Female; HIV Seropositivity; HIV-1; Humans; K | 1993 |
Pentoxifylline therapy in HIV seropositive subjects with elevated TNF.
Topics: Adolescent; Adult; Aged; Cachexia; Cross-Over Studies; Female; Flow Cytometry; HIV Seropositivity; H | 1995 |
Pentoxifylline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: a randomized, controlled trial.
Topics: Adult; beta 2-Microglobulin; Double-Blind Method; HIV Seropositivity; Humans; Pentoxifylline; Phosph | 1996 |
Pentoxifylline improves cell-mediated immunity and reduces human immunodeficiency virus (HIV) plasma viremia in asymptomatic HIV-seropositive persons.
Topics: Adjuvants, Immunologic; Anti-HIV Agents; Apoptosis; CD4 Lymphocyte Count; Cytokines; Drug Therapy, C | 1997 |
Pruritus in HIV-1 disease: therapy with drugs which may modulate the pattern of immune dysregulation.
Topics: Administration, Cutaneous; Administration, Topical; Anti-Inflammatory Agents; Antipruritics; Cycloox | 1997 |